
insit

insit hii eka american bahurashtriy aushadh company aahe jiche mukhyalay wilmington, delaware aanee morges, switzerland yethe aahe.
1991 madhye californiatil palo aulto yethe sthapan jhalelya insite pharmaceuticals aanee insite genomics, ink. yanchya vilinikaranadvare 2002 madhye companychi nirmiti karnyat aalee. delaveray. company sadhya uttar america, europe aanee ashiyamadhye utpadan aanee sanshodhan aanee vikas kendre chalavate.
insit corporation sadhya karkarogshastra, jaljal aanee svayampratirodhakatesaha anek upcharatmak kshetranmadhye prescription biopharmaceutical aushadhe vikasit aanee tayar karate.
itihas.
2014 madhye, insit herve hoppenotche adhyaksh aanee mukhya karyakari adhikari mhanoon niyukt jhaale aanee 2015 madhye tyanchi sanchalak mandalache adhyaksh mhanoon niyukti karnyat aalee. hoppenot yanni yapurvi novartis oncologyche adhyaksh mhanoon kaam kele hote; teey 2003 pasoon novartisasobat hote.
september 2015 madhye, companyne jaheer kele qee tyala jiangsu hengrui medicine companyshi sambandhit vishesh vikas aanee vyavsayik adhikar midale aahet., limitedchi anty-peedi-1 monoclonal antibody, sr-1210,795 + dashalaksh dollarschya kararat.
janewari 2020 madhye, insitne morphosisus tafasitamabchya jaagtik vikasasathi aanee vyavsayikaranasathi sahkarya aanee parwana kararavar swakshya kelya. 3 march 2020 roji yaa kararala avishvas manjuri midali aanee tyamule too prabhavi jhaala.
aushadhanirman.
insit corporationkade sadhya jakafi (ruxolitinib), pemazir (pemigatinib), monjuvi (tafacitamab-cx), opzelura (ruxolitinib), tabrecta (capmatinib), olumient (barricitinib) aanee eclusig (ponatinib) yasah saat vipanan aanee saha-vipanan keleli aushadh utpadane aahet.
2013 madhye, novartisne insiteche see-mett inhibitor capmatinib (ink280, inkabi028060) vikat ghetale, jeey tabrecta yaa brand navane vikale jaate.
2014 paryant, company ellie lilichya bhagidarit sandhivatasathi maukhik jacq 1 aanee jacq 2 avarodhak aushadh, barricitinib vikasit karat hotee. februwari 2017 madhye tyala european unionchi manjuri midali. april 2017 madhye, us fdane matra aanee surakshitatebaddalachya chinteche kaaran dett nakar jaaree keela. meey 2018 madhye, united statesmadhye sandhivatachya upcharasathi barricitinibla olumient yaa brand navane manyata denyat aalee.
2016 paryant, epacadostat, eka indolamine 2,3-dioxygeness (ido1) avarodhak, vividh karkarogansathi vikasit hott hota aanee markchya pembrolisumab (kitruda) aanee bristall myers squibchya nivolumab (opdivo) saha sanyukt chachanyanmadhye hota.